메뉴 건너뛰기




Volumn 5, Issue 1, 2012, Pages 115-124

Base excision repair factors are promising prognostic and predictive markers in cancer

Author keywords

APE1; Base excision repair; Cancer; Chemotherapy; DNA repair; ERCC1; Pol ; Predictive marker; Prognostic marker; Radiotherapy; XRCC1

Indexed keywords

ALKYLATING AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA TOPOISOMERASE INHIBITOR; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MESSENGER RNA; METHOTREXATE; OXALIPLATIN; PLATINUM; TUMOR MARKER;

EID: 84855853057     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467211205010115     Document Type: Article
Times cited : (17)

References (104)
  • 1
    • 0037421590 scopus 로고    scopus 로고
    • Pharmacogenomics--drug disposition, drug targets, and side effects
    • Evans, W.E.; McLeod, H.L. Pharmacogenomics--drug disposition, drug targets, and side effects. N. Engl. J. Med., 2003, 348(6), 538-549.
    • (2003) N. Engl. J. Med , vol.348 , Issue.6 , pp. 538-549
    • Evans, W.E.1    McLeod, H.L.2
  • 2
    • 25144480988 scopus 로고    scopus 로고
    • Genetic susceptibility to iatrogenic malignancy
    • Allan, J.M.; Rabkin, C.S. Genetic susceptibility to iatrogenic malignancy. Pharmacogenomics, 2005, 6(6), 615-28.
    • (2005) Pharmacogenomics , vol.6 , Issue.6 , pp. 615-628
    • Allan, J.M.1    Rabkin, C.S.2
  • 3
    • 3342953639 scopus 로고    scopus 로고
    • Simple and complex genetics of colorectal cancer susceptibility
    • Baglioni, S.; Genuardi, M. Simple and complex genetics of colorectal cancer susceptibility. Am. J. Med. Genet. C. Semin. Med. Genet., 2004, 129C (1), 35-43.
    • (2004) Am. J. Med. Genet. C. Semin. Med. Genet , vol.129 C , Issue.1 , pp. 35-43
    • Baglioni, S.1    Genuardi, M.2
  • 4
    • 34548252915 scopus 로고    scopus 로고
    • DNA base excision repair as a biomarker in molecular epidemiology studies
    • Collins, A.R.; Gaivao, I. DNA base excision repair as a biomarker in molecular epidemiology studies. Mol. Aspects Med., 2007, 28(3-4), 307-322.
    • (2007) Mol. Aspects Med , vol.28 , Issue.3-4 , pp. 307-322
    • Collins, A.R.1    Gaivao, I.2
  • 5
    • 22244477048 scopus 로고    scopus 로고
    • XRCC1 polymorphisms and cancer risk: A meta-analysis of 38 case-control studies
    • Hu, Z.; Ma, H.; Chen, F.; Wei, Q.; Shen, H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev., 2005, 14 (7), 1810-1818.
    • (2005) Cancer Epidemiol. Biomarkers Prev , vol.14 , Issue.7 , pp. 1810-1818
    • Hu, Z.1    Ma, H.2    Chen, F.3    Wei, Q.4    Shen, H.5
  • 6
    • 27744531188 scopus 로고    scopus 로고
    • Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review
    • Hung, R.J.; Hall, J.; Brennan, P.; Boffetta, P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol., 2005, 162 (10), 925-942.
    • (2005) Am. J. Epidemiol , vol.162 , Issue.10 , pp. 925-942
    • Hung, R.J.1    Hall, J.2    Brennan, P.3    Boffetta, P.4
  • 7
    • 33750311904 scopus 로고    scopus 로고
    • Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis
    • Kiyohara, C.; Takayama, K.; Nakanishi, Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer, 2006, 54(3), 267-283.
    • (2006) Lung Cancer , vol.54 , Issue.3 , pp. 267-283
    • Kiyohara, C.1    Takayama, K.2    Nakanishi, Y.3
  • 8
    • 1342266756 scopus 로고    scopus 로고
    • The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk
    • Park, J.; Chen, L.; Tockman, M.S.; Elahi, A.; Lazarus, P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics, 2004, 14(2), 103-109.
    • (2004) Pharmacogenetics , vol.14 , Issue.2 , pp. 103-109
    • Park, J.1    Chen, L.2    Tockman, M.S.3    Elahi, A.4    Lazarus, P.5
  • 9
    • 34548292501 scopus 로고    scopus 로고
    • Base excision repair modulation as a risk factor for human cancers
    • Tudek, B. Base excision repair modulation as a risk factor for human cancers. Mol. Aspects Med., 2007, 28(3-4), 258-75.
    • (2007) Mol. Aspects Med , vol.28 , Issue.3-4 , pp. 258-275
    • Tudek, B.1
  • 10
    • 70449688321 scopus 로고    scopus 로고
    • The DNA repair gene APE1 T1349G polymorphism and cancer risk: A metaanalysis of 27 case-control studies
    • Gu, D.; Wang, M.; Wang, M.; Zhang, Z.; Chen, J. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a metaanalysis of 27 case-control studies. Mutagenesis, 2009, 24(6), 507-512.
    • (2009) Mutagenesis , vol.24 , Issue.6 , pp. 507-512
    • Gu, D.1    Wang, M.2    Wang, M.3    Zhang, Z.4    Chen, J.5
  • 11
    • 13944281044 scopus 로고    scopus 로고
    • Polymorphic variation in hOGG1 and risk of cancer: A review of the functional and epidemiologic literature
    • Weiss, J.M.; Goode, E.L.; Ladiges, W.C.; Ulrich, C.M. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol. Carcinog., 2005, 42(3), 127-141.
    • (2005) Mol. Carcinog , vol.42 , Issue.3 , pp. 127-141
    • Weiss, J.M.1    Goode, E.L.2    Ladiges, W.C.3    Ulrich, C.M.4
  • 12
    • 3943107573 scopus 로고    scopus 로고
    • Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
    • Sancar, A.; Lindsey-Boltz, L.A.; Unsal-Kacmaz, K.; Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem., 2004, 73, 39-85.
    • (2004) Annu. Rev. Biochem , vol.73 , pp. 39-85
    • Sancar, A.1    Lindsey-Boltz, L.A.2    Unsal-Kacmaz, K.3    Linn, S.4
  • 13
    • 33847007529 scopus 로고    scopus 로고
    • The mechanics of base excision repair, and its relationship to aging and disease
    • Wilson, D.M. 3rd; Bohr, V.A. The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst), 2007, 6(4), 544-559.
    • (2007) DNA Repair (Amst) , vol.6 , Issue.4 , pp. 544-559
    • Wilson 3rd., D.M.1    Bohr, V.A.2
  • 14
    • 34247599335 scopus 로고    scopus 로고
    • A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification
    • Almeida, K.H.; Sobol, R.W. A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst), 2007, 6 (6), 695-711.
    • (2007) DNA Repair (Amst) , vol.6 , Issue.6 , pp. 695-711
    • Almeida, K.H.1    Sobol, R.W.2
  • 16
    • 34548276529 scopus 로고    scopus 로고
    • The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target
    • Fishel, M.L.; Kelley, M.R., The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol. Aspects Med., 2007, 28(3-4), 375-395.
    • (2007) Mol. Aspects Med , vol.28 , Issue.3-4 , pp. 375-395
    • Fishel, M.L.1    Kelley, M.R.2
  • 17
    • 77955095659 scopus 로고    scopus 로고
    • endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer
    • Abbotts, R.; Madhusudan, S. Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer. Cancer Treat. Rev., 2010, 36(5), 425-35.
    • (2010) Cancer Treat. Rev , vol.36 , Issue.5 , pp. 425-435
    • Abbotts, R.1    Madhusudan, S.2    Human, A.P.3
  • 18
    • 58849147871 scopus 로고    scopus 로고
    • Going ape as an approach to cancer therapeutics
    • Bapat, A.; Fishel, M.L.; Kelley, M.R., Going ape as an approach to cancer therapeutics. Antioxid. Redox Signal., 2009, 11(3), 651-668.
    • (2009) Antioxid. Redox Signal , vol.11 , Issue.3 , pp. 651-668
    • Bapat, A.1    Fishel, M.L.2    Kelley, M.R.3
  • 19
    • 0029829265 scopus 로고    scopus 로고
    • The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice
    • Xanthoudakis, S.; Smeyne, R.J.; Wallace, J.D.; Curran, T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc. Natl. Acad. Sci. USA, 1996, 93(17), 8919-8923.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , Issue.17 , pp. 8919-8923
    • Xanthoudakis, S.1    Smeyne, R.J.2    Wallace, J.D.3    Curran, T.4
  • 20
    • 0036718792 scopus 로고    scopus 로고
    • The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress
    • Silber, J.R.; Bobola, M.S.; Blank, A.; Schoeler, K.D.; Haroldson, P.D.; Huynh, M.B.; Kolstoe, D.D. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress. Clin. Cancer Res., 2002, 8(9), 3008-3018.
    • (2002) Clin. Cancer Res , vol.8 , Issue.9 , pp. 3008-3018
    • Silber, J.R.1    Bobola, M.S.2    Blank, A.3    Schoeler, K.D.4    Haroldson, P.D.5    Huynh, M.B.6    Kolstoe, D.D.7
  • 21
    • 4444327784 scopus 로고    scopus 로고
    • Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: Enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition
    • Wang, D.; Luo, M.; Kelley, M.R. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol. Cancer Ther., 2004, 3(6), 679-686.
    • (2004) Mol. Cancer Ther , vol.3 , Issue.6 , pp. 679-686
    • Wang, D.1    Luo, M.2    Kelley, M.R.3
  • 22
    • 27144474248 scopus 로고    scopus 로고
    • Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors
    • Bobola, M.S.; Finn, L.S.; Ellenbogen, R.G.; Geyer, J.R.; Berger, M.S.; Braga, J.M.; Meade, E.H.; Gross, M.E.; Silber, J.R. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin. Cancer Res., 2005, 11(20), 7405-7414.
    • (2005) Clin. Cancer Res , vol.11 , Issue.20 , pp. 7405-7414
    • Bobola, M.S.1    Finn, L.S.2    Ellenbogen, R.G.3    Geyer, J.R.4    Berger, M.S.5    Braga, J.M.6    Meade, E.H.7    Gross, M.E.8    Silber, J.R.9
  • 23
    • 5044238690 scopus 로고    scopus 로고
    • Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides
    • Lau, J.P.; Weatherdon, K.L.; Skalski, V.; Hedley, D.W. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br. J. Cancer, 2004, 91(6), 1166-1173.
    • (2004) Br. J. Cancer , vol.91 , Issue.6 , pp. 1166-1173
    • Lau, J.P.1    Weatherdon, K.L.2    Skalski, V.3    Hedley, D.W.4
  • 24
    • 0028244814 scopus 로고
    • Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease
    • Ono, Y.; Furuta, T.; Ohmoto, T.; Akiyama, K.; Seki, S., Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease. Mutat. Res., 1994, 315(1), 55-63.
    • (1994) Mutat. Res , vol.315 , Issue.1 , pp. 55-63
    • Ono, Y.1    Furuta, T.2    Ohmoto, T.3    Akiyama, K.4    Seki, S.5
  • 25
    • 0028596574 scopus 로고
    • A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress
    • Walker, L.J.; Craig, R.B.; Harris, A.L.; Hickson, I.D., A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res., 1994, 22(23), 4884-4889.
    • (1994) Nucleic Acids Res , vol.22 , Issue.23 , pp. 4884-4889
    • Walker, L.J.1    Craig, R.B.2    Harris, A.L.3    Hickson, I.D.4
  • 26
    • 70350622182 scopus 로고    scopus 로고
    • APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells
    • Wang, D.; Xiang, D.B.; Yang, X.Q.; Chen, L.S.; Li, M.X.; Zhong, Z.Y.; Zhang, Y.S. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Lung Cancer, 2009, 66(3), 298-304.
    • (2009) Lung Cancer , vol.66 , Issue.3 , pp. 298-304
    • Wang, D.1    Xiang, D.B.2    Yang, X.Q.3    Chen, L.S.4    Li, M.X.5    Zhong, Z.Y.6    Zhang, Y.S.7
  • 27
    • 73749084430 scopus 로고    scopus 로고
    • Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms
    • Zhang, R.; Niu, Y.; Zhou, Y. Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms. Toxicol. Lett., 2010, 192(2), 108-114.
    • (2010) Toxicol. Lett , vol.192 , Issue.2 , pp. 108-114
    • Zhang, R.1    Niu, Y.2    Zhou, Y.3
  • 29
    • 33847666362 scopus 로고    scopus 로고
    • Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein
    • Mitra, S.; Izumi, T.; Boldogh, I.; Bhakat, K.K.; Chattopadhyay, R.; Szczesny, B., Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein. DNA Repair (Amst), 2007, 6(4), 461-469.
    • (2007) DNA Repair (Amst) , vol.6 , Issue.4 , pp. 461-469
    • Mitra, S.1    Izumi, T.2    Boldogh, I.3    Bhakat, K.K.4    Chattopadhyay, R.5    Szczesny, B.6
  • 30
    • 14044269479 scopus 로고    scopus 로고
    • The intracellular localization of APE1/Ref-1: More than a passive phenomenon?
    • Tell, G.; Damante, G.; Caldwell, D.; Kelley, M.R., The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid. Redox. Signal., 2005, 7(3-4), 367-384.
    • (2005) Antioxid. Redox. Signal , vol.7 , Issue.3-4 , pp. 367-384
    • Tell, G.1    Damante, G.2    Caldwell, D.3    Kelley, M.R.4
  • 31
  • 33
    • 0041378046 scopus 로고    scopus 로고
    • XRCC1 and DNA strand break repair
    • Caldecott, K.W. XRCC1 and DNA strand break repair. DNA Repair (Amst), 2003, 2(9), 955-969.
    • (2003) DNA Repair (Amst) , vol.2 , Issue.9 , pp. 955-969
    • Caldecott, K.W.1
  • 35
    • 15244341766 scopus 로고    scopus 로고
    • Micronuclei in EM9 cells expressing polymorphic forms of human XRCC1
    • Qu, T.; Morii, E.; Oboki, K.; Lu, Y.; Morimoto, K. Micronuclei in EM9 cells expressing polymorphic forms of human XRCC1. Cancer Lett., 2005, 221(1), 91-95.
    • (2005) Cancer Lett , vol.221 , Issue.1 , pp. 91-95
    • Qu, T.1    Morii, E.2    Oboki, K.3    Lu, Y.4    Morimoto, K.5
  • 36
    • 0346243565 scopus 로고    scopus 로고
    • Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays
    • Au, W.W.; Salama, S.A.; Sierra-Torres, C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect., 2003, 111(15), 1843-1850.
    • (2003) Environ. Health Perspect , vol.111 , Issue.15 , pp. 1843-1850
    • Au, W.W.1    Salama, S.A.2    Sierra-Torres, C.H.3
  • 37
    • 0036208101 scopus 로고    scopus 로고
    • Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair
    • Taylor, R.M.; Thistlethwaite, A.; Caldecott, K.W. Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol. Cell Biol., 2002, 22(8), 2556-2563.
    • (2002) Mol. Cell Biol , vol.22 , Issue.8 , pp. 2556-2563
    • Taylor, R.M.1    Thistlethwaite, A.2    Caldecott, K.W.3
  • 38
    • 33645116504 scopus 로고    scopus 로고
    • Mouse models of XRCC1 DNA repair polymorphisms and cancer
    • Ladiges, W.C. Mouse models of XRCC1 DNA repair polymorphisms and cancer. Oncogene, 2006, 25(11), 1612-1619.
    • (2006) Oncogene , vol.25 , Issue.11 , pp. 1612-1619
    • Ladiges, W.C.1
  • 39
    • 69249220333 scopus 로고    scopus 로고
    • XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: A metaanalysis
    • Geng, J.; Zhang, Q.; Zhu, C.; Wang, J.; Chen, L. XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a metaanalysis. Urology, 2009, 74(3), 648-653.
    • (2009) Urology , vol.74 , Issue.3 , pp. 648-653
    • Geng, J.1    Zhang, Q.2    Zhu, C.3    Wang, J.4    Chen, L.5
  • 40
    • 67349253065 scopus 로고    scopus 로고
    • XRCC1 gene polymorphisms and breast cancer risk in different populations: A meta-analysis
    • Li, H.; Ha, T.C.; Tai, B.C. XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast, 2009, 18(3), 183-191.
    • (2009) Breast , vol.18 , Issue.3 , pp. 183-191
    • Li, H.1    Ha, T.C.2    Tai, B.C.3
  • 42
    • 45849105603 scopus 로고    scopus 로고
    • Genetic polymorphisms and head and neck cancer risk (Review)
    • Hiyama, T.; Yoshihara, M.; Tanaka, S.; Chayama, K. Genetic polymorphisms and head and neck cancer risk (Review). Int. J. Oncol., 2008, 32(5), 945-973.
    • (2008) Int. J. Oncol , vol.32 , Issue.5 , pp. 945-973
    • Hiyama, T.1    Yoshihara, M.2    Tanaka, S.3    Chayama, K.4
  • 43
    • 77952544071 scopus 로고    scopus 로고
    • The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection
    • Kang, C.H.; Jang, B.G.; Kim, D.W.; Chung, D.H.; Kim, Y.T.; Jheon, S.; Sung, S.W.; Kim, J.H. The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection. Lung Cancer, 2010, 68(3), 478-483.
    • (2010) Lung Cancer , vol.68 , Issue.3 , pp. 478-483
    • Kang, C.H.1    Jang, B.G.2    Kim, D.W.3    Chung, D.H.4    Kim, Y.T.5    Jheon, S.6    Sung, S.W.7    Kim, J.H.8
  • 45
    • 73949096486 scopus 로고    scopus 로고
    • Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: The FOCUS trial
    • Braun, M.S.; Richman, S.D.; Thompson, L.; Daly, C.L.; Meade, A.M.; Adlard, J.W.; Allan, J.M.; Parmar, M.K.; Quirke, P.; Seymour, M.T. Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial. J. Clin. Oncol., 2009, 27(33), 5519-5528.
    • (2009) J. Clin. Oncol , vol.27 , Issue.33 , pp. 5519-5528
    • Braun, M.S.1    Richman, S.D.2    Thompson, L.3    Daly, C.L.4    Meade, A.M.5    Adlard, J.W.6    Allan, J.M.7    Parmar, M.K.8    Quirke, P.9    Seymour, M.T.10
  • 46
    • 67249087934 scopus 로고    scopus 로고
    • polymerase beta polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity
    • Guo, Z.; Zheng, L.; Dai, H.; Zhou, M.; Xu, H.; Shen, B. Human DNA polymerase beta polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity. Nucleic Acids Res., 2009, 37(10), 3431-3441.
    • (2009) Nucleic Acids Res , vol.37 , Issue.10 , pp. 3431-3441
    • Guo, Z.1    Zheng, L.2    Dai, H.3    Zhou, M.4    Xu, H.5    Shen, B.6    Human, D.N.A.7
  • 50
    • 28644440431 scopus 로고    scopus 로고
    • Polymorphisms of the human OGG1 gene in laryngeal cancer: Implications in radiotherapy response and survival
    • Monteiro, E.; Varzim, G.; Silva, R.; da Costa, B.; Lopes, C. Polymorphisms of the human OGG1 gene in laryngeal cancer: implications in radiotherapy response and survival. Rev. Laryngol. Otol. Rhinol. (Bord), 2005, 126(3), 135-140.
    • (2005) Rev. Laryngol. Otol. Rhinol. (Bord) , vol.126 , Issue.3 , pp. 135-140
    • Monteiro, E.1    Varzim, G.2    Silva, R.3    da Costa, B.4    Lopes, C.5
  • 51
    • 0028969271 scopus 로고
    • Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
    • Cox, J.D.; Stetz, J.; Pajak, T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys., 1995, 31(5), 1341-1346.
    • (1995) Int. J. Radiat. Oncol. Biol. Phys , vol.31 , Issue.5 , pp. 1341-1346
    • Cox, J.D.1    Stetz, J.2    Pajak, T.F.3
  • 52
    • 70449585523 scopus 로고    scopus 로고
    • Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor
    • Zhang, Y.; Wang, J.; Xiang, D.; Wang, D.; Xin, X. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Int. J. Oncol., 2009, 35(5), 1069-1079.
    • (2009) Int. J. Oncol , vol.35 , Issue.5 , pp. 1069-1079
    • Zhang, Y.1    Wang, J.2    Xiang, D.3    Wang, D.4    Xin, X.5
  • 55
    • 77952888002 scopus 로고    scopus 로고
    • Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy
    • Fareed, K.R.; Al-Attar, A.; Soomro, I.N.; Kaye, P.V.; Patel, J.; Lobo, D.N.; Parsons, S. L.; Madhusudan, S. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. Br. J. Cancer, 2010, 102(11), 1600-1607.
    • (2010) Br. J. Cancer , vol.102 , Issue.11 , pp. 1600-1607
    • Fareed, K.R.1    Al-Attar, A.2    Soomro, I.N.3    Kaye, P.V.4    Patel, J.5    Lobo, D.N.6    Parsons, S.L.7    Madhusudan, S.8
  • 57
    • 43049102429 scopus 로고    scopus 로고
    • Alteration of APE1/ref-1 expression in non-small cell lung cancer: The implications of impaired extracellular superoxide dismutase and catalase antioxidant systems
    • Yoo, D.G.; Song, Y.J.; Cho, E.J.; Lee, S.K.; Park, J.B.; Yu, J.H.; Lim, S.P.; Kim, J.M.; Jeon, B.H. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer, 2008, 60(2), 277-284.
    • (2008) Lung Cancer , vol.60 , Issue.2 , pp. 277-284
    • Yoo, D.G.1    Song, Y.J.2    Cho, E.J.3    Lee, S.K.4    Park, J.B.5    Yu, J.H.6    Lim, S.P.7    Kim, J.M.8    Jeon, B.H.9
  • 59
    • 0034905642 scopus 로고    scopus 로고
    • Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer
    • Kelley, M.R.; Cheng, L.; Foster, R.; Tritt, R.; Jiang, J.; Broshears, J.; Koch, M. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin. Cancer Res., 2001, 7(4), 824-830.
    • (2001) Clin. Cancer Res , vol.7 , Issue.4 , pp. 824-830
    • Kelley, M.R.1    Cheng, L.2    Foster, R.3    Tritt, R.4    Jiang, J.5    Broshears, J.6    Koch, M.7
  • 61
    • 0035266131 scopus 로고    scopus 로고
    • Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation
    • Robertson, K.A.; Bullock, H.A.; Xu, Y.; Tritt, R.; Zimmerman, E.; Ulbright, T.M.; Foster, R.S.; Einhorn, L.H.; Kelley, M.R. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res., 2001, 61(5), 2220-2225.
    • (2001) Cancer Res , vol.61 , Issue.5 , pp. 2220-2225
    • Robertson, K.A.1    Bullock, H.A.2    Xu, Y.3    Tritt, R.4    Zimmerman, E.5    Ulbright, T.M.6    Foster, R.S.7    Einhorn, L.H.8    Kelley, M.R.9
  • 62
    • 34247172071 scopus 로고    scopus 로고
    • Genetic polymorphisms and treatment response in advanced non-small cell lung cancer
    • Su, D.; Ma, S.; Liu, P.; Jiang, Z.; Lv, W.; Zhang, Y.; Deng, Q.; Smith, S.; Yu, H. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer, 2007, 56(2), 281-288.
    • (2007) Lung Cancer , vol.56 , Issue.2 , pp. 281-288
    • Su, D.1    Ma, S.2    Liu, P.3    Jiang, Z.4    Lv, W.5    Zhang, Y.6    Deng, Q.7    Smith, S.8    Yu, H.9
  • 63
    • 34247374739 scopus 로고    scopus 로고
    • Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials
    • Kuptsova, N.; Kopecky, K.J.; Godwin, J.; Anderson, J.; Hoque, A.; Willman, C.L.; Slovak, M.L.; Ambrosone, C.B. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood, 2007, 109(9), 3936-3944.
    • (2007) Blood , vol.109 , Issue.9 , pp. 3936-3944
    • Kuptsova, N.1    Kopecky, K.J.2    Godwin, J.3    Anderson, J.4    Hoque, A.5    Willman, C.L.6    Slovak, M.L.7    Ambrosone, C.B.8
  • 64
    • 58549098021 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients
    • Figl, A.; Scherer, D.; Nagore, E.; Bermejo, J.L.; Dickes, E.; Thirumaran, R.K.; Gast, A.; Hemminki, K.; Kumar, R.; Schadendorf, D. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients. Mutat. Res., 2009, 661(1-2), 78-84.
    • (2009) Mutat. Res , vol.661 , Issue.1-2 , pp. 78-84
    • Figl, A.1    Scherer, D.2    Nagore, E.3    Bermejo, J.L.4    Dickes, E.5    Thirumaran, R.K.6    Gast, A.7    Hemminki, K.8    Kumar, R.9    Schadendorf, D.10
  • 65
    • 77952315609 scopus 로고    scopus 로고
    • Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers
    • Yao, C.Y.; Huang, X.E.; Li, C.; Shen, H.B.; Shi, M.Q.; Feng, J.F.; Pan, L.X.; Tang, J.H. Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers. Asian Pac. J. Cancer Prev., 2009, 10(5), 859-864.
    • (2009) Asian Pac. J. Cancer Prev , vol.10 , Issue.5 , pp. 859-864
    • Yao, C.Y.1    Huang, X.E.2    Li, C.3    Shen, H.B.4    Shi, M.Q.5    Feng, J.F.6    Pan, L.X.7    Tang, J.H.8
  • 66
    • 34848869833 scopus 로고    scopus 로고
    • Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?
    • Suh, K.W.; Kim, J.H.; Kim do, Y.; Kim, Y.B.; Lee, C.; Choi, S. Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene? Ann. Surg. Oncol., 2006, 13(11), 1379-1385.
    • (2006) Ann. Surg. Oncol , vol.13 , Issue.11 , pp. 1379-1385
    • Suh, K.W.1    Kim, J.H.2    Kim do, Y.3    Kim, Y.B.4    Lee, C.5    Choi, S.6
  • 67
    • 0035174375 scopus 로고    scopus 로고
    • A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer
    • Stoehlmacher, J.; Ghaderi, V.; Iobal, S.; Groshen, S.; Tsao-Wei, D.; Park, D.; Lenz, H.J. A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res., 2001, 21(4B), 3075-3079.
    • (2001) Anticancer Res , vol.21 , Issue.4 B , pp. 3075-3079
    • Stoehlmacher, J.1    Ghaderi, V.2    Iobal, S.3    Groshen, S.4    Tsao-Wei, D.5    Park, D.6    Lenz, H.J.7
  • 68
    • 16644395637 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer
    • Wang, Z.H.; Miao, X.P.; Tan, W.; Zhang, X.R.; Xu, B.H.; Lin, D.X. Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer. Ai Zheng, 2004, 23(8), 865-868.
    • (2004) Ai Zheng , vol.23 , Issue.8 , pp. 865-868
    • Wang, Z.H.1    Miao, X.P.2    Tan, W.3    Zhang, X.R.4    Xu, B.H.5    Lin, D.X.6
  • 69
    • 4344567395 scopus 로고    scopus 로고
    • XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced nonsmall- cell lung cancer patients treated with platinum chemotherapy
    • Gurubhagavatula, S.; Liu, G.; Park, S.; Zhou, W.; Su, L.; Wain, J.C.; Lynch, T.J.; Neuberg, D.S.; Christiani, D.C. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced nonsmall- cell lung cancer patients treated with platinum chemotherapy. J. Clin. Oncol., 2004, 22(13), 2594-2601.
    • (2004) J. Clin. Oncol , vol.22 , Issue.13 , pp. 2594-2601
    • Gurubhagavatula, S.1    Liu, G.2    Park, S.3    Zhou, W.4    Su, L.5    Wain, J.C.6    Lynch, T.J.7    Neuberg, D.S.8    Christiani, D.C.9
  • 72
    • 78549288382 scopus 로고    scopus 로고
    • Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism
    • Hong, C.Y.; Xu, Q.; Yue, Z.; Zhang, Y.; Yuan, Y. Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism. Ai Zheng, 2009, 28(12), 1291-1297.
    • (2009) Ai Zheng , vol.28 , Issue.12 , pp. 1291-1297
    • Hong, C.Y.1    Xu, Q.2    Yue, Z.3    Zhang, Y.4    Yuan, Y.5
  • 77
    • 34247893863 scopus 로고    scopus 로고
    • Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan
    • Martinez-Balibrea, E.; Manzano, J.L.; Martinez-Cardus, A.; Moran, T.; Cirauqui, B.; Catot, S.; Taron, M.; Abad, A. Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan. Oncol. Rep., 2007, 17(3), 637-645.
    • (2007) Oncol. Rep , vol.17 , Issue.3 , pp. 637-645
    • Martinez-Balibrea, E.1    Manzano, J.L.2    Martinez-Cardus, A.3    Moran, T.4    Cirauqui, B.5    Catot, S.6    Taron, M.7    Abad, A.8
  • 78
    • 3843130823 scopus 로고    scopus 로고
    • A multivariate analysis of genomic polymorphisms: Prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer
    • Stoehlmacher, J.; Park, D.J.; Zhang, W.; Yang, D.; Groshen, S.; Zahedy, S.; Lenz, H.J. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br. J. Cancer, 2004, 91(2), 344-354.
    • (2004) Br. J. Cancer , vol.91 , Issue.2 , pp. 344-354
    • Stoehlmacher, J.1    Park, D.J.2    Zhang, W.3    Yang, D.4    Groshen, S.5    Zahedy, S.6    Lenz, H.J.7
  • 79
    • 77954677109 scopus 로고    scopus 로고
    • The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer
    • Liang, J.; Jiang, T.; Yao, R.Y.; Liu, Z.M.; Lv, H. Y.; Qi, W.W. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer. Cancer Chemother. Pharmacol., 2010, 66(3), 493-500.
    • (2010) Cancer Chemother. Pharmacol , vol.66 , Issue.3 , pp. 493-500
    • Liang, J.1    Jiang, T.2    Yao, R.Y.3    Liu, Z.M.4    Lv, H.Y.5    Qi, W.W.6
  • 80
    • 34848912861 scopus 로고    scopus 로고
    • Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatinbased chemotherapy in Chinese population
    • Liu, B.; Wei, J.; Zou, Z.; Qian, X.; Nakamura, T.; Zhang, W.; Ding, Y.; Feng, J.; Yu, L. Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatinbased chemotherapy in Chinese population. Eur. J. Hum. Genet., 2007, 15(10), 1049-1053.
    • (2007) Eur. J. Hum. Genet , vol.15 , Issue.10 , pp. 1049-1053
    • Liu, B.1    Wei, J.2    Zou, Z.3    Qian, X.4    Nakamura, T.5    Zhang, W.6    Ding, Y.7    Feng, J.8    Yu, L.9
  • 83
    • 75149128076 scopus 로고    scopus 로고
    • DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients
    • Bachmann, H.S.; Rubben, H.; Schmid, K.W.; Siffert, W.; Riemann, K. DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients. Anticancer Res., 2009, 29(12), 5131-5135.
    • (2009) Anticancer Res , vol.29 , Issue.12 , pp. 5131-5135
    • Bachmann, H.S.1    Rubben, H.2    Schmid, K.W.3    Siffert, W.4    Riemann, K.5
  • 84
    • 34250213645 scopus 로고    scopus 로고
    • Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer
    • Jaremko, M.; Justenhoven, C.; Schroth, W.; Abraham, B.K.; Fritz, P.; Vollmert, C.; Illig, T.; Simon, W.; Schwab, M.; Brauch, H. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer. Pharmacogenet. Genomics, 2007, 17(7), 529-538.
    • (2007) Pharmacogenet. Genomics , vol.17 , Issue.7 , pp. 529-538
    • Jaremko, M.1    Justenhoven, C.2    Schroth, W.3    Abraham, B.K.4    Fritz, P.5    Vollmert, C.6    Illig, T.7    Simon, W.8    Schwab, M.9    Brauch, H.10
  • 85
    • 34247122055 scopus 로고    scopus 로고
    • Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer
    • Bewick, M.A.; Conlon, M.S.; Lafrenie, R.M. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J. Clin. Oncol., 2006, 24(36), 5645-5651.
    • (2006) J. Clin. Oncol , vol.24 , Issue.36 , pp. 5645-5651
    • Bewick, M.A.1    Conlon, M.S.2    Lafrenie, R.M.3
  • 86
    • 33748324572 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy
    • Sakano, S.; Wada, T.; Matsumoto, H.; Sugiyama, S.; Inoue, R.; Eguchi, S.; Ito, H.; Ohmi, C.; Matsuyama, H.; Naito, K. Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br. J. Cancer, 2006, 95(5), 561-70.
    • (2006) Br. J. Cancer , vol.95 , Issue.5 , pp. 561-570
    • Sakano, S.1    Wada, T.2    Matsumoto, H.3    Sugiyama, S.4    Inoue, R.5    Eguchi, S.6    Ito, H.7    Ohmi, C.8    Matsuyama, H.9    Naito, K.10
  • 87
    • 56149116930 scopus 로고    scopus 로고
    • XRCC1 codon 399 mutant allele: A risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
    • Mittal, R.D.; Singh, R.; Manchanda, P.K.; Ahirwar, D.; Gangwar, R.; Kesarwani, P.; Mandhani, A. XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Cancer Biol. Ther., 2008, 7(5), 645-650.
    • (2008) Cancer Biol. Ther , vol.7 , Issue.5 , pp. 645-650
    • Mittal, R.D.1    Singh, R.2    Manchanda, P.K.3    Ahirwar, D.4    Gangwar, R.5    Kesarwani, P.6    Mandhani, A.7
  • 89
    • 33751425930 scopus 로고    scopus 로고
    • XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer
    • Chung, H.H.; Kim, M.K.; Kim, J.W.; Park, N.H.; Song, Y.S.; Kang, S.B.; Lee, H.P. XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer. Gynecol. Oncol., 2006, 103(3), 1031-1037.
    • (2006) Gynecol. Oncol , vol.103 , Issue.3 , pp. 1031-1037
    • Chung, H.H.1    Kim, M.K.2    Kim, J.W.3    Park, N.H.4    Song, Y.S.5    Kang, S.B.6    Lee, H.P.7
  • 90
    • 68249162551 scopus 로고    scopus 로고
    • The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma
    • Cheng, X.D.; Lu, W.G.; Ye, F.; Wan, X.Y.; Xie, X. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. J. Exp. Clin. Cancer Res., 2009, 28, 91.
    • (2009) J. Exp. Clin. Cancer Res , vol.28 , pp. 91
    • Cheng, X.D.1    Lu, W.G.2    Ye, F.3    Wan, X.Y.4    Xie, X.5
  • 91
    • 56449096906 scopus 로고    scopus 로고
    • XRCC1 Arginine194Tryptophan and GGH- 401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer
    • Kim, K.; Kang, S.B.; Chung, H.H.; Kim, J.W.; Park, N.H.; Song, Y.S. XRCC1 Arginine194Tryptophan and GGH- 401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol, 2008, 111(3), 509-515.
    • (2008) Gynecol Oncol , vol.111 , Issue.3 , pp. 509-515
    • Kim, K.1    Kang, S.B.2    Chung, H.H.3    Kim, J.W.4    Park, N.H.5    Song, Y.S.6
  • 93
    • 77954415447 scopus 로고    scopus 로고
    • Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer
    • Gao, R.; Price, D.K.; Dahut, W.L.; Steinberg, S.M.; Reed, E.; Figg, W.D. Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. Cancer Biol. Ther., 2010, 10(1), 13-18.
    • (2010) Cancer Biol. Ther , vol.10 , Issue.1 , pp. 13-18
    • Gao, R.1    Price, D.K.2    Dahut, W.L.3    Steinberg, S.M.4    Reed, E.5    Figg, W.D.6
  • 95
    • 77950208798 scopus 로고    scopus 로고
    • Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes
    • Alsbeih, G.; Al-Harbi, N.; Al-Hadyan, K.; El-Sebaie, M.; Al-Rajhi, N. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat. Res., 2010, 173(4), 505-511.
    • (2010) Radiat. Res , vol.173 , Issue.4 , pp. 505-511
    • Alsbeih, G.1    Al-Harbi, N.2    Al-Hadyan, K.3    El-Sebaie, M.4    Al-Rajhi, N.5
  • 96
    • 46449108180 scopus 로고    scopus 로고
    • Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer
    • Burri, R.J.; Stock, R.G.; Cesaretti, J.A.; Atencio, D.P.; Peters, S.; Peters, C.A.; Fan, G.; Stone, N.N.; Ostrer, H.; Rosenstein, B.S. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat. Res., 2008, 170(1), 49-59.
    • (2008) Radiat. Res , vol.170 , Issue.1 , pp. 49-59
    • Burri, R.J.1    Stock, R.G.2    Cesaretti, J.A.3    Atencio, D.P.4    Peters, S.5    Peters, C.A.6    Fan, G.7    Stone, N.N.8    Ostrer, H.9    Rosenstein, B.S.10
  • 97
    • 52149093686 scopus 로고    scopus 로고
    • XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population
    • Wang, Z.; Xu, B.; Lin, D.; Tan, W.; Leaw, S.; Hong, X.; Hu, X. XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. Lung Cancer, 2008, 62(1), 99-104.
    • (2008) Lung Cancer , vol.62 , Issue.1 , pp. 99-104
    • Wang, Z.1    Xu, B.2    Lin, D.3    Tan, W.4    Leaw, S.5    Hong, X.6    Hu, X.7
  • 100
    • 0344198151 scopus 로고    scopus 로고
    • Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy
    • Moullan, N.; Cox, D.G.; Angele, S.; Romestaing, P.; Gerard, J.P.; Hall, J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomarkers Prev., 2003, 12(11 Pt. 1), 1168-1174.
    • (2003) Cancer Epidemiol. Biomarkers Prev , vol.12 , Issue.11 Pt. 1 , pp. 1168-1174
    • Moullan, N.1    Cox, D.G.2    Angele, S.3    Romestaing, P.4    Gerard, J.P.5    Hall, J.6
  • 101
    • 0344676392 scopus 로고    scopus 로고
    • Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes
    • Andreassen, C.N.; Alsner, J.; Overgaard, M.; Overgaard, J., Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol., 2003, 69(2), 127-135.
    • (2003) Radiother Oncol , vol.69 , Issue.2 , pp. 127-135
    • Andreassen, C.N.1    Alsner, J.2    Overgaard, M.3    Overgaard, J.4
  • 102
    • 33748577313 scopus 로고    scopus 로고
    • Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples
    • Andreassen, C.N.; Alsner, J.; Overgaard, M.; Sorensen, F.B.; Overgaard, J. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples. Int. J. Radiat. Biol., 2006, 82(8), 577-586.
    • (2006) Int. J. Radiat. Biol , vol.82 , Issue.8 , pp. 577-586
    • Andreassen, C.N.1    Alsner, J.2    Overgaard, M.3    Sorensen, F.B.4    Overgaard, J.5
  • 103
    • 18144374862 scopus 로고    scopus 로고
    • TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer
    • Andreassen, C.N.; Alsner, J.; Overgaard, J.; Herskind, C.; Haviland, J.; Owen, R.; Homewood, J.; Bliss, J.; Yarnold, J. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother. Oncol., 2005, 75(1), 18-21.
    • (2005) Radiother. Oncol , vol.75 , Issue.1 , pp. 18-21
    • Andreassen, C.N.1    Alsner, J.2    Overgaard, J.3    Herskind, C.4    Haviland, J.5    Owen, R.6    Homewood, J.7    Bliss, J.8    Yarnold, J.9
  • 104
    • 21244472962 scopus 로고    scopus 로고
    • Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes
    • De Ruyck, K.; Van Eijkeren, M.; Claes, K.; Morthier, R.; De Paepe, A.; Vral, A.; De Ridder, L.; Thierens, H. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int. J. Radiat. Oncol. Biol. Phys., 2005, 62(4), 1140-1149.
    • (2005) Int. J. Radiat. Oncol. Biol. Phys , vol.62 , Issue.4 , pp. 1140-1149
    • de Ruyck, K.1    van Eijkeren, M.2    Claes, K.3    Morthier, R.4    de Paepe, A.5    Vral, A.6    de Ridder, L.7    Thierens, H.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.